The Market Impact of the COVID-19 Pandemic on the Pharma Industry

By Miranda Greenberg -

October 8, 2020

An upcoming DCAT webinar, featuring Graham Lewis, Vice President, Global Pharma Strategy, IQVIA, evaluates the market impact on the COVID-19 pandemic on companies’ pipelines, product launches, and performance and how industry fundamentals and growth prospects have been affected.

The 90-minute interactive webinar, “Pipelines, Product Launches, and Performance: The Market Impact of COVID-19 on the Pharma Industry," will be held on Tuesday October 27, 2020 from 11:00 AM to 12:30 PM ET. It will provide up-to-the-minute market data and analysis on the current state and medium-term outlook of the global pharmaceutical industry. It will delve deeply into these crucial questions: (1) how have industry fundamentals been impacted in terms of growth prospects and product development; (2) what is the impact and projections for new product launches and the industry’s pipeline; and (3) what may be the “new normal” for the pharma industry, and what can the industry expect going forward?

Further information, including how to register, may be found here.